Ines Mende

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi Flk2+ myeloid progenitors are the main source of Langerhans cells
    Ines Mende
    Stanford Blood Center, 3373 Hillview Ave, Palo Alto, CA 94304, USA
    Blood 107:1383-90. 2006
  2. ncbi Developmental origin of interferon-alpha-producing dendritic cells from hematopoietic precursors
    Holger Karsunky
    Department of Pathology, Stanford University School of Medicine, Stanford, Calif, USA
    Exp Hematol 33:173-81. 2005
  3. ncbi Breaking tolerance to tumors with dendritic cell-based immunotherapy
    Ines Mende
    Department of Pathology, Stanford University School of Medicine, Palo Alto, California 94305, USA
    Ann N Y Acad Sci 1058:96-104. 2005
  4. ncbi Breaking self-tolerance to tumor-associated antigens by in vivo manipulation of dendritic cells
    Ines Mende
    Department of Pathology, Stanford University School of Medicine, Palo Alto, CA, USA
    Methods Mol Biol 380:457-68. 2007
  5. ncbi High levels of the onco-protein Gfi-1 accelerate T-cell proliferation and inhibit activation induced T-cell death in Jurkat T-cells
    Holger Karsunky
    , IFZ, , Virchowstrasse 173, D-45122 Essen, Germany
    Oncogene 21:1571-9. 2002
  6. ncbi A subset of human dendritic cells in the T cell area of mucosa-associated lymphoid tissue with a high potential to produce TNF-alpha
    Annegret de Baey
    Micromet AG, Munich, Germany
    J Immunol 170:5089-94. 2003
  7. ncbi Highly efficient antigen targeting to M-DC8+ dendritic cells via FcgammaRIII/CD16-specific antibody conjugates
    Ines Mende
    Micromet AG, Staffelseestrasse 2, 81477 Munich, Germany
    Int Immunol 17:539-47. 2005
  8. ncbi Incorporation of CpG oligonucleotide ligand into protein-loaded particle vaccines promotes antigen-specific CD8 T-cell immunity
    Stephany M Standley
    Department of Chemistry, University of California, Berkeley, California 94729 1460, USA
    Bioconjug Chem 18:77-83. 2007

Collaborators

Detail Information

Publications8

  1. ncbi Flk2+ myeloid progenitors are the main source of Langerhans cells
    Ines Mende
    Stanford Blood Center, 3373 Hillview Ave, Palo Alto, CA 94304, USA
    Blood 107:1383-90. 2006
    ..These results indicate that LCs are derived mainly from myeloid progenitors and are dependent on Flt3-ligand for their development...
  2. ncbi Developmental origin of interferon-alpha-producing dendritic cells from hematopoietic precursors
    Holger Karsunky
    Department of Pathology, Stanford University School of Medicine, Stanford, Calif, USA
    Exp Hematol 33:173-81. 2005
    ....
  3. ncbi Breaking tolerance to tumors with dendritic cell-based immunotherapy
    Ines Mende
    Department of Pathology, Stanford University School of Medicine, Palo Alto, California 94305, USA
    Ann N Y Acad Sci 1058:96-104. 2005
    ..Two approaches to DC targeting are described in this review, both of which have been shown to overcome immune tolerance to tumors and induce dramatic tumor regression...
  4. ncbi Breaking self-tolerance to tumor-associated antigens by in vivo manipulation of dendritic cells
    Ines Mende
    Department of Pathology, Stanford University School of Medicine, Palo Alto, CA, USA
    Methods Mol Biol 380:457-68. 2007
    ..Strategies that allow DC to gain access to both tumor antigens and TLR agonists, in situ, can overcome tumor tolerance leading to the induction of potent systemic antitumor immunity...
  5. ncbi High levels of the onco-protein Gfi-1 accelerate T-cell proliferation and inhibit activation induced T-cell death in Jurkat T-cells
    Holger Karsunky
    , IFZ, , Virchowstrasse 173, D-45122 Essen, Germany
    Oncogene 21:1571-9. 2002
    ..These findings suggest that Gfi-1 contributes to T-cell lymphomagenesis by overriding a late G1 cell cycle checkpoint which controls activation induced death and S phase entry of T-cells...
  6. ncbi A subset of human dendritic cells in the T cell area of mucosa-associated lymphoid tissue with a high potential to produce TNF-alpha
    Annegret de Baey
    Micromet AG, Munich, Germany
    J Immunol 170:5089-94. 2003
    ..We infer that selective elimination of M-DC8(+) cells in inflammatory diseases has therapeutic potential...
  7. ncbi Highly efficient antigen targeting to M-DC8+ dendritic cells via FcgammaRIII/CD16-specific antibody conjugates
    Ines Mende
    Micromet AG, Staffelseestrasse 2, 81477 Munich, Germany
    Int Immunol 17:539-47. 2005
    ..Our data demonstrate that specific antigen targeting via CD16 on M-DC8(+) DC is a promising vaccination approach for the efficient induction of specific CD4(+) T cell responses ex vivo, and perhaps in vivo...
  8. ncbi Incorporation of CpG oligonucleotide ligand into protein-loaded particle vaccines promotes antigen-specific CD8 T-cell immunity
    Stephany M Standley
    Department of Chemistry, University of California, Berkeley, California 94729 1460, USA
    Bioconjug Chem 18:77-83. 2007
    ....